A major private hospital group has warned that a reimbursement cap under the Central Government Health Scheme is straining finances for hospitals treating advanced cancer. The cap on life-saving immunotherapy drugs is pushing essential medicines beyond affordability for many CGHS beneficiaries, according to the association, which says nine specific drugs are now out of reach and may limit access to treatment.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
